Diagnosis of epithelial ovarian cancer using a combined protein biomarker panel

    Research output: Contribution to journalArticle

    • Matthew R. Russell
    • Ciaren Graham
    • Alfonsina D’Amato
    • Aleksandra Gentry-Maharaj
    • Andy Ryan
    • Jatinderpal K. Kalsi
    • Anthony D. Whetton
    • Usha Menon
    • Ian Jacobs
    • Robert L. J. Graham

    View graph of relations

    BackgroundAn early detection tool for EOC was constructed from analysis of biomarker expression data from serum collected during the UKCTOCS.MethodsThis study included 49 EOC cases (19 Type I and 30 Type II) and 31 controls, representing 482 serial samples spanning seven years pre-diagnosis. A logit model was trained by analysis of dysregulation of expression data of four putative biomarkers, (CA125, phosphatidylcholine-sterol acyltransferase, vitamin K-dependent protein Z and C-reactive protein); by scoring the specificity associated with dysregulation from the baseline expression for each individual.ResultsThe model is discriminatory, passes k-fold and leave-one-out cross-validations and was further validated in a Type I EOC set. Samples were analysed as a simulated annual screening programme, the algorithm diagnosed cases with >30% PPV 1–2 years pre-diagnosis. For Type II cases (~80% were HGS) the algorithm classified 64% at 1 year and 28% at 2 years tDx as severe.ConclusionsThe panel has the potential to diagnose EOC one-two years earlier than current diagnosis. This analysis provides a tangible worked example demonstrating the potential for development as a screening tool and scrutiny of its properties. Limits on interpretation imposed by the number of samples available are discussed.


    • Diagnosis of epithelial ovarian cancer using a combined protein biomarker panel

      Rights statement: Copyright 2019 the authors. This is an open access article published under a Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.

      Final published version, 913 KB, PDF-document


    Original languageEnglish
    JournalBritish Journal of Cancer
    Journal publication date07 Aug 2019
    Publication statusPublished - 07 Aug 2019

    ID: 179518499